29 Aug, 2023 Going green, literally – (slow) legalization of cannabis in Germany By Philip Weyand Guido Kleve Dylan Kennett Cannabis for adult-use is no longer a clandestine indulgence anymore, but a thriving industry in certain countries globally. Germany...
22 Feb, 2022 Use of cannabis and derived substances in cosmetics – Portuguese approach By Mariana Ricardo Ana Rita Santos The Portuguese National Authority for Medications and Health Products (INFARMED) issued a bulletin on the topic of the usage of cannabis...
18 Feb, 2022 A new chapter in France's CBD legal saga By Marion Abecassis Marion de Galembert In an expected order of 24 January 2022, the interim relief judge of the French Administrative Supreme Court (Conseil d’Etat – “CE”)...
15 Feb, 2021 Ireland: Cannabis Medical Access Programme By Caoimhe Clarkin Louise McErlean Cannabis remains a controlled substance in most jurisdictions, but demand for medicinal and wellbeing cannabis products and their...
18 Dec, 2020 Low dose CBD medications to be available without prescription in Australia By Greg Bodulovic On 15 December 2020, the Australian Therapeutic Goods Administration (TGA) published its decision to down-schedule certain low dose...
25 Nov, 2020 CBD product liability issues – taking proactive steps to mitigate risk By David Jaroslaw As the legal landscape for hemp continues to evolve, manufacturers and sellers of CBD products face increased challenges, such as an...
20 Nov, 2020 Kanavape: a victory for CBD producers across Europe By Rahool Sarjua The Court of Justice of the European Union (CJEU) has ruled that EU Member States cannot prohibit the marketing of cannabidiol (CBD)...
06 Nov, 2020 CBD as a novel food: the UK's stance post-Brexit By Rahool Sarjua The UK FSA's announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the...
10 Sep, 2020 The wait is not over for approved medicinal CBD in Australia By Greg Bodulovic We previously reported in our article “Developments in Australian CBD market” that the Pharmaceutical Benefits Advisory Committee (PBAC)...
13 Jul, 2020 Australia moves to facilitate legal export of cannabis and hemp By Alexandra Moore Greg Bodulovic The Australian Government has moved to further bolster the local cannabis industry with the passing of the Export Control Legislation...
21 May, 2020 Developments in Australian CBD market By Alexandra Moore Greg Bodulovic The cannabidiol (CBD) medicine market in Australia is set to grow. At present, there are no medicinal CBD products registered on the...
04 May, 2020 Australia considers over-the-counter CBD By Alexandra Moore Greg Bodulovic The Therapeutic Goods Administration (TGA) – Australia’s regulatory body for pharmaceuticals and medical devices – is proposing to...
13 Feb, 2020 DEADLINE DAY: FSA gives the CBD industry until 31 March 2021 to submit novel food applications By Rahool Sarjua By Rahool Sarjua and Kahwing Fung, 13 February 2020 2019 was a big year for cannabidiol (CBD) based products with new products appearing...